Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effect of Antioxidants on the Immune Response and Wound Healing in Critically Ill Patients
This study is not yet open for participant recruitment.
Study NCT00487097   Information provided by Rabin Medical Center
First Received: June 14, 2007   No Changes Posted

June 14, 2007
June 14, 2007
September 2007
 
Improvement of wound healing of pressure sores [ Time Frame: within 28 days ]
Same as current
No Changes Posted
Improvement in parameters of immunity and inflammation [ Time Frame: Within 28 days ]
Same as current
 
The Effect of Antioxidants on the Immune Response and Wound Healing in Critically Ill Patients
Effect of EPA, GLA and Antioxidants on the Immune Response - Cellular and Molecular Mechanisms of Wound Healing in Critically Ill Patients.

The purpose of this study is to investigate whether the addition of omega-3 and antioxidants to nutritional support in critically ill patients in the intensive care unit influences the immune and anti-inflammatory sytems and so improves wound healing.

A prospective randomized study to include 40 consecutive patients admitted to the general intensive care unit. The control group will receive nutritional support composed of a standard formula. The study group will receive nutritional support enriched with fish oil and anti-oxidants. The following variables will be assessed in all patients: demographics, severity of illness, assessment of bed sores. Blood tests will also be taken for the following: CD 8, CD 14, CD 18, CD 11a, CD49c, CD 49d. In addition, blood samples will be collected for TNF, IL-1b, IL-6, IL-8, and levels of C-reactive protein. Metabolic parametere such as resting energy expenditure, BMI, albumin, prealbumin, levels of zinc, relationship between omega 3 and omega 6. Theses test will be performed at time of ICU admission, days 7, 14 and 28 after admission.

The outcome: improved repair of pressure sores, together with improvement in objective parameters of immunity and inflammation.

 
Interventional
Treatment, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
  • Pressure Sores
  • Intensive Care
Drug: Ecosopentanoic acid, docosahexaenoic acid
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Not yet recruiting
40
September 2008
 

Inclusion Criteria:

  • Critically ill patients in intensive care unit
  • Grade 2 pressure sores

Exclusion Criteria:

  • Immunosupression with steroids or other agents
  • Active bleeding
  • Head trauma
Both
18 Years to 85 Years
No
Contact: Pierre Singer, MD +972 3 937 6521 psinger@clalit.org.il
Contact: Miriam Theilla, RN +972 3 937 6524 theilla@012.net.il
Israel
 
NCT00487097
 
4428
Rabin Medical Center
 
Principal Investigator: Pierre Singer Rabin Medical Center, Beilison Hospital, Israel
Rabin Medical Center
June 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP